Ditching the double chin

A drug designed to shrink unwanted chin fat looks set to go to market in the US.

Deoxycholic acid in injectable form is awaiting final approval from the FDA to treat submental fat, better known as double chin.

If successful, the drug known as ATX-101, will be the first medical treatment for excess chin fat, says Dr Lynne Drake, committee chair of the FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee, which has recommended the drug’s approval.

Dr Drake is convinced  the product answers an